Posts Categorized: Uncategorized

Safety information March 23, 2020: Epipen autoinjector devices

It has come to the attention of IFAN that there are potential safety issues as follows: “The FDA in the USA is alerting patients, caregivers and health care professionals that EpiPen 0.3 mg and EpiPen Jr 0.15 mg Auto-Injectors, and the authorized generic versions, may potentially have delayed injection or be prevented from properly injecting… Read more »

Coronavirus (COVID 19) and Allergy

For all patients at risk of anaphylaxis: -have 2 in-date adrenaline autoinjectors. It’s important to be prepared at this time as it can be harder to access GPs and pharmacies. -if in doubt give adrenaline and call an ambulance: EVEN during this public health emergency. Families are advised to ensure they have adequate stock of… Read more »

Approval of peanut allergy treatment in the US.

The Food and Drug Administration in the US has approved immunotherapy as a treatment to mitigate the risk of allergic reactions that may occur, including anaphylaxis, after accidental exposure to peanut in patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. To see the press release issued by the American Academy… Read more »

EAACI 2020 comes to London

The EAACI Congress 2020 will take place from June 6th to 10th 2020, in London, United Kingdom. Organised by the European Academy of Allergy and Clinical Immunology (EAACI), the largest medical association in its field in Europe, the EAACI Congress 2020 offers a unique opportunity to learn about the latest discoveries. The congress activities will… Read more »

School hit with €3.5 thousand penalty for discrimination due to nut allergy

IFAN welcomes the judgement of November 11th 2019 by the Workplace Relations Commission (WRC) that a pupil with food allergies was discriminated against by a school’s failure to provide reasonable accommodations to attend a school trip and that other options were not explored to assist travel and partake in an exchange programme. This is the second… Read more »

Adrenaline training.

The Pre Hospital Emergency Care Council are responsible under law for approving and accrediting providers of training courses in Ireland for emergency cardiac first response (CFR) including giving adrenaline (Epinephrine). If you are in need of training please visit this link which will bring you to the PHECC website. In the second search box “Course Name… Read more »

Travel Bursary

A limited number of travel grants are now being offered by IFAN to members presenting original work, relevant to the field of Food Allergy at an International meeting. To be eligible for a grant, the applicant must be: The first author of an abstract (in the field of food allergy) accepted to an international meeting…. Read more »

Peanut immunotherapy trial results: desensitisation in peanut allergic children

A trial of oral immunotherapy in children and adolescents highly allergic to peanut, treated with AR101 resulted in higher doses of peanut protein that could be ingested without dose-limiting symptoms according to research published yesterday. To see the RTE news clip featuring an Irish participant and commentary from Professor Hourihane, Paediatric Allergist at Cork University Hospital… Read more »

Advisory notice: Emerade Adrenaline Autoinjector devices.

The Health Products Regulatory Authority (HPRA) wishes to inform users and healthcare professionals of the following potential quality defect for the Emerade range of treatments There is a possibility that a small percentage (0.015%) of Emerade pens on the Irish market may not deliver a dose of adrenaline. This is due to the potential for… Read more »